Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Mucosal Melanoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2331 Carcinoma, Non-Small-Cell Lung 1896 Prostatic Neoplasms 1228 Colorectal Neoplasms 1078 Neoplasms 1043 Multiple Myeloma 909 Lung Neoplasms 870 Neoplasm Metastasis 852 Leukemia, Myeloid, Acute 825 Lymphoma 752 Melanoma 737 Pancreatic Neoplasms 698 Ovarian Neoplasms 679 Carcinoma, Hepatocellular 650 Recurrence 645 Stomach Neoplasms 641 Leukemia 631 Lymphoma, Non-Hodgkin 573 Leukemia, Lymphocytic, Chronic, B-Cell 553 Lymphoma, Large B-Cell, Diffuse 526 Squamous Cell Carcinoma of Head and Neck 520 Precursor Cell Lymphoblastic Leukemia-Lymphoma 506 Head and Neck Neoplasms 505 Brain Neoplasms 502 Glioblastoma 494 Carcinoma, Renal Cell 485 Rectal Neoplasms 481 Myelodysplastic Syndromes 442 Sarcoma 432 Lymphoma, Follicular 432

Interventions

camrelizumab 1 apatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03986515 2019-06-14

Apatinib Plus SHR1210 in Advanced Mucosal Melanoma

Henan Cancer Hospital

Phase 2 Unknown

Mucosal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡